Angel Medical Systems, Inc. is a medical device company that specializes in developing and manufacturing continuous intracardiac ischemia monitoring and alerting devices for patients. The company's flagship product, the AngelMed Guardian system, is an implantable cardiac device designed to detect significant changes in heart signals that may indicate serious cardiac events, such as coronary artery occlusions due to vulnerable plaque ruptures. The system comprises an internal implantable device that monitors and records vital heart data, alerts patients through vibrations, and tracks ST segment deviations compared to heart rate for an extended period. Additionally, it includes an external telemetry device that provides auditory and visual alerts, and a programmer that allows healthcare providers to evaluate heart signals and manage patient data effectively. Founded in 2001, Angel Medical Systems is headquartered in Shrewsbury, New Jersey.
NeuroPace designs and markets implantable neuromodulation systems for neurological disorders, with a focus on epilepsy. Its flagship RNS System includes an implantable neurostimulator connected to depth and cortical leads that monitor brain activity and deliver targeted, responsive electrical stimulation to seizure onset regions. External components, including a programmer and software, enable device configuration and monitoring. Founded in 1997 and based in Mountain View, California, the company generates most revenue from selling RNS Systems to hospital facilities for implantation in patients with medically refractory partial epilepsy. NeuroPace aims to reduce or eliminate seizures through adaptive neuromodulation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.